Phase 4 Type 1 Diabetes Trial, Recruiting (NCT07293715)

Phase 4 Type 1 Diabetes Trial, Recruiting NCT07293715 Sponsor: Ohio State University Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07293715 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are pregnant
You are 18 years old or older
You have Type 1 diabetes
You are planning to give birth vaginally and have been admitted to the labor and delivery unit
You are carrying a single baby with no major birth defects
You are at least 35 weeks pregnant
Your cervix is opened less than 6 centimeters (early stage of labor)
You are giving birth at the hospital where this study is taking place

Who may not be able to join:

You are scheduled to have a cesarean section (C-section)
Your cervix is already opened 6 centimeters or more when you arrive at the labor and delivery unit
You have received steroid injections (antenatal corticosteroids) within the last 7 days before joining the study
There has been a loss of the baby before birth
The baby has been found to have a major birth defect (confirm with trial site for specific details)
You are carrying more than one baby (such as twins or triplets)
You do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Anna Brewton, MD, Ohio State University

Phone: 614-293-8045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07293715

Sponsor: Ohio State University

Phase: Phase 4

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 614-293-8045

More information: https://clinicaltrials.gov/study/NCT07293715

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are pregnant
You are 18 years old or older
You have Type 1 diabetes
You are planning to give birth vaginally and have been admitted to the labor and delivery unit
You are carrying a single baby with no major birth defects
You are at least 35 weeks pregnant
Your cervix is opened less than 6 centimeters (early stage of labor)
You are giving birth at the hospital where this study is taking place

Who may not be able to join:

You are scheduled to have a cesarean section (C-section)
Your cervix is already opened 6 centimeters or more when you arrive at the labor and delivery unit
You have received steroid injections (antenatal corticosteroids) within the last 7 days before joining the study
There has been a loss of the baby before birth
The baby has been found to have a major birth defect (confirm with trial site for specific details)
You are carrying more than one baby (such as twins or triplets)
You do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Ohio State University

Registry

ClinicalTrials.gov

Start date

25 February 2026

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean of first neonatal blood glucose (continuous, mean with standard deviation)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov